Module

Current Challenges in Cancer Immunotherapy

Source: Tumor Immunology: Treatment Approaches With Immunotherapies in Human Cancer

Current Challenges in Cancer Immunotherapy

Program Director: John M. Kirkwood, MD

Faculty:

Cassian Yee, MD

CME CREDIT INFORMATION

Release Date: 10/17/07

Expiration Date: 10/16/08

Physicians: maximum of 1.25 AMA PRA Category 1 Credits™

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss the mechanisms by which tumors escape immune surveillance
Summarize antitumor immunotherapies currently in development
Cite malignancies for which immunotherapeutic strategies are being developed
Describe toxicities associated with immunotherapies

Topics covered include:

Introduction
Cancers Associated With Immunosuppression
Cancers Associated With Viral Antigens
Cancers for Which Tumor-Reactive T-Cell Responses Can Be Elicited
Immune Escape Mechanisms
The Clinical Setting for Immunotherapy
Immunotherapy Toxicity
Conclusions

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.